Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 38

Results For "NIT"

6211 News Found

Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
News | June 03, 2026

Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia

Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market


Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business
People | June 03, 2026

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'
News | June 03, 2026

Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'

At the center of the project is a new cosmetics line developed through collaboration between industry and medicine


Lupin and Natco get FDA approval for Eribulin Mesylate injection
Drug Approval | June 03, 2026

Lupin and Natco get FDA approval for Eribulin Mesylate injection

Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


Marksans Pharma to acquire Netherlands-based QliniQ
News | June 02, 2026

Marksans Pharma to acquire Netherlands-based QliniQ

Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets


FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG
Drug Approval | June 02, 2026

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death


Ebola vax on the anvil?
News | June 02, 2026

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate